Charles Schwab Investment Management Inc. Increases Stock Position in Harrow, Inc. (NASDAQ:HROW)

Charles Schwab Investment Management Inc. lifted its holdings in Harrow, Inc. (NASDAQ:HROW) by 195.9% during the third quarter, Holdings Channel reports. The institutional investor owned 251,629 shares of the company’s stock after acquiring an additional 166,602 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Harrow were worth $11,313,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the business. Oppenheimer & Co. Inc. purchased a new stake in Harrow in the third quarter worth about $1,267,000. SG Americas Securities LLC purchased a new stake in shares of Harrow in the 3rd quarter worth approximately $534,000. Semanteon Capital Management LP bought a new position in Harrow during the 3rd quarter valued at approximately $686,000. Private Capital Management LLC raised its stake in Harrow by 7.8% during the first quarter. Private Capital Management LLC now owns 3,012,393 shares of the company’s stock valued at $39,854,000 after buying an additional 217,896 shares during the last quarter. Finally, Apis Capital Advisors LLC purchased a new position in Harrow during the second quarter valued at $1,660,000. 72.76% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on HROW shares. B. Riley lowered their price target on Harrow from $73.00 to $69.00 and set a “buy” rating for the company in a research report on Wednesday, December 4th. Craig Hallum lifted their target price on shares of Harrow from $45.00 to $65.00 and gave the stock a “buy” rating in a report on Friday, October 4th. Finally, Lake Street Capital increased their price target on shares of Harrow from $45.00 to $55.00 and gave the company a “buy” rating in a report on Friday, October 4th.

Harrow Price Performance

Shares of NASDAQ:HROW opened at $39.95 on Tuesday. The company has a debt-to-equity ratio of 3.23, a quick ratio of 1.44 and a current ratio of 1.55. The firm has a market cap of $1.42 billion, a price-to-earnings ratio of -42.50 and a beta of 0.69. The business has a 50-day simple moving average of $46.99 and a two-hundred day simple moving average of $35.65. Harrow, Inc. has a fifty-two week low of $9.13 and a fifty-two week high of $59.23.

Harrow Profile

Harrow, Inc operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc and changed its name to Harrow Health, Inc in December 2018. Harrow Health, Inc was incorporated in 2006 and is headquartered in Nashville, Tennessee.